First Page | Document Content | |
---|---|---|
![]() Date: 2012-12-31 18:21:38Anatomy Amyotrophic lateral sclerosis ALS Society of Canada Progressive muscular atrophy Fasciculation Primary lateral sclerosis Spinal and bulbar muscular atrophy Riluzole Pseudobulbar affect Motor neurone disease Health Rare diseases | Add to Reading List |
![]() | Masitinib for amyotrophic lateral sclerosis – add-on therapy to riluzoleDocID: 1gqBs - View Document |
![]() | Practice advisory on the treatment of amyotrophic lateral sclerosis with riluzoleDocID: 17z0L - View Document |
![]() | Dear (Name of your Congressional and Senatorial Official at the Federal Level), I am writing to express interest in the approval status of a bio-drug produced by Genervon Biopharmaceuticals LLS, known as GM604 or GM6DocID: 173Yp - View Document |
![]() | Executive Summary: Towards Improving Outcomes for Patients with ALSDocID: 14ZbG - View Document |
![]() | AMYOTROPHIC LATERAL SCLEROSIS (ALS) (also known as Lou Gehrig’s Disease) DISEASE FACT SHEET AND OPPORTUNITY FOR TIRASEMTIV What is ALS? About Us Cytokinetics is a clinical-stage biopharmaceutical companyDocID: 13OuA - View Document |